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Abstract.  We show by immunohistology that distinct 
expression patterns of the four muscle regulatory fac- 
tor (MRF) proteins identify subdomains of mouse so- 
mites.  Myf-5 and MyoD are, at specific stages, each 
expressed in both myotome and dermatome cells. 
Myf-5 expression is initially restricted to dorsal cells 
in all somites, as is MyoD expression in neck somites. 
In trunk somites, however, MyoD is initially expressed 
in ventral cells. Myogenin and MRF4 are restricted 
to myotome cells, though the MRF4-expressing cells 
are initially less widely distributed than the myogenin- 
expressing cells, which are at all stages found through- 
out the myotome. All somitic myocytes express one or 
more MRFs. The transiently distinct expression pat- 
terns of the four MRF proteins identify dorsal and 
ventral subdomains of somites, and suggest that skele- 
tal muscle cells in somites originate at multiple sites 
and via multiple molecular pathways. 
Lof the skeletal  muscle cells in the trunk and limbs 
are formed by myogenic  cells that originate in the 
somites (Christ et al., 1977; Chevallier et ai., 1977; 
Kermy-Mobbs,  1985). Somitic myogenesis does not appear 
to be a single process, rather multiple  lineages of myogenic 
cells appear to arise in distinct regions ofa somite. Myogenic 
cells which originate in the dorsal-medial region of a somite 
(nearest the neural tube) form axial muscles, whereas myo- 
genic cells which originate in the ventral-lateral half of a so- 
mite migrate and form muscles in the limbs and ventral body 
wall  (Ordahl  and  Le  Douarin,  1992).  The  neural  tube/ 
notochord is required for myogenic cells to form in the dor- 
sal-medial, but not ventral-lateral,  region of a somite (Or- 
dahl and Le Douarin, 1992; Rong et al., 1992). The descen- 
dants of myogenic cells in the somites are further subdivided 
into multiple types of embryonic, fetal,  and satellite  cell 
myoblasts (reviewed by Cossu and Molinaro,  1987; Miller, 
1992; Stockdale, 1992; Miller et al., 1993). The cellular and 
molecular mechanisms  underlying the generation  and diver- 
sification of myogenic cells are not fully understood, though 
the muscle-specific transcription  factors of the MyoD family 
likely play a central  role. 
MyoD,  myogenin,  Myf-5,  and  MRF4/Myf-6/herculin 
comprise the basic helix-loop-helix  group of muscle regula- 
tory factors (MRFs)  l (reviewed by Weintraub  et al.,  1991; 
Olson, 1992). The MRFs act in concert with additional ubiq- 
uitous and  muscle-specific transcription  regulators to ac- 
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tivate transcription  of many muscle-specific  genes.  In situ 
hybridization has been used to determine the expression pat- 
terns of the MRF mRNAs (reviewed by Buckingham,  1992; 
Sassoon,  1993).  The  first  MRF mRNAs to be detected, 
Myf-5 in the mouse and qmfl and 3 in the quail,  are found 
in the dorsal-medial quadrant of epithelial stage somites (Ott 
et al.,  1991; Pownall and Emerson,  1992).  The remaining 
MRF mRNAs then appear sequentially;  e.g., in rodent so- 
mites,  Myf-5 mRNA is followed by the myogenin,  MRF4, 
and MyoD mRNAs (Ott et al.,  1991; Hinterberger et al., 
1991). 
New questions  about MRF function  in the somites have 
been raised by recent work. Different  studies  have, for ex- 
ample,  reached varying conclusions about where myogenic 
cells originate  in the somites (summarized  by Kaehn et al., 
1988). In addition,  studies of mice with deleted MRF genes 
suggest that: (a) Myf-5 is required to properly form not only 
the myotomes but also the distal ribs (Braun et al.,  1992;) 
(b) MyoD appears dispensable during  somitic  myogenesis 
(Rudnicki et al., 1992); (c) lack of myogenin greatly reduces 
myotube formation  in vivo (Hasty et al.,  1993; Nabeshima 
et al., 1993); and (d) either Myf-5 or MyoD is required for 
myoblast formation (Rudnicki et al., 1993). Cusella-De An- 
gelis et al. (1992) concluded that E9.5 mouse somites contain 
untranslated  myogenin mRNA, and that some somitic mus- 
cle cells in vivo and in vitro express myosin heavy chain 
(MHC), but not the myogenin or MyoD proteins.  We found 
that E8.5 mouse somite cells formed myocytes in culture that 
contained MHC but did not have detectable amounts of any 
of the four MRFs (Smith  et al.,  1993). 
Further understanding  of how the MRFs function  in so- 
mitic myogenesis clearly requires knowledge  of MRF pro- 
tein expression  patterns in individual  somite cells.  Because 
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bodies (Wright et al., 1991; Mak et al., 1992; Smith et al., 
1993) to determine where and when the four MRF proteins 
are expressed in mouse somites. We find that each MRF pro- 
tein has a distinct expression pattern in the somites. These 
unexpectedly complex MRF expression patterns define sub- 
domains in somites and suggest that myogenic cells arise in 
the  somites  via  multiple  cellular  origins  and  molecular 
pathways. 
Materials and Methods 
Myosin heavy chain proteins were detected with mAb F59, an IgG1, which 
reacts with all known striated muscle MHC isoforms in the mouse, but does 
not react with smooth muscle or cytoskeletal MHCs (Miller et al.,  1985, 
1989;  Miller and Stockdale,  1986a,b;  Miller,  1990;  Smith and Miller, 
1992).  Myogenin protein was detected with the mouse anti-myogenin mAb 
F5D, an IgGl, which was provided by Dr. W. E. Wright (University of  Texas 
Southwestern Medical School, Dallas, TX) (Wright et ai., 1991; Cusella-De 
Angelis et ai., 1992). The MyoD, Myf-5, and MRF4 proteins were detected 
with the same three polyclonal antisera which were used in previous work 
(Smith et ai.,  1993)  and were provided by Dr.  S. E  Konieczny (Purdue 
University,  Lafayette,  IN).  The  anti-MRF  sera were prepared by  Drs. 
Konieczny and S. J. Rhodes using glutathione-S-transferase-MyoD, -Myf-5, 
or -MRF4 fusion proteins as immunngens, and the specific reaction of each 
antiserum with a single MRF was confirmed by both imrnunoprecipitation 
and immunofluorescence analyses (Smith et al.,  1993). 
Embryos were obtained from timed pregnant females of the outbred CD- 
1 strain of mice (Charles River Breeding Laboratories, Wilmington, MA). 
After dissection and fixation (see below), the number of somite pairs was 
counted and noted for each embryo to be analyzed. Embryos of 8.5-d gesta- 
tion (E8.5)  typically bad 7-12 somite pairs, E9 embryos had 16-22 somite 
pairs, E9.5 embryos bad 24-28 somite pairs, and El0.5 embryos had 34-38 
somite pairs. Somites are numbered from head to tall, with the most rostral 
being number  1.  To compare MRF expression patterns among different 
groups of somites, those somites numbered 1-8 are termed "neck; somites 
8-12 are termed "forelimb bud  ~, somites 11-24 are termed "trunk; somites 
25-29 are termed "hindlimb bud" (Milalre, 1976),  and somites numbered 
>I 30 are termed "tall: Somites numbers 11 and 12 are included with both 
forelimb bud and trunk somites, because they are adjacent to the forelimb 
bud and also appear to contribute to the ribs (Theiler, 1989).  The number 
of an individual somite could be determined within one in reconstructions 
of serial sections. We therefore adopted the convention of Hinterberger et 
al. (1991),  in which a somite known, for example, to be either number 8 
or number 9 is referred to as somite 8/9. 
For analyses of tissue sections, E8.5-E10.5 embryos were dissected free 
of external membranes, immediately placed in PBS supplemented with 4 % 
paraformaldehyde, and incubated overnight at 4"C with agitation. Fixed 
embryos were subjected to two washes of 30 rain each in PBS at room tem- 
perature, followed by incubation for 2 h at room temperature in PBS con- 
taining 2% bovine serum albumin, 2% normal horse serum, 2% normal 
goat serum, and 0.1% Triton X-100 (blocking solution). Fixed and blocked 
embryos were infiltrated with sucrose by sequential incubations of 3 h at 
room temperature in blocking solution modified to contain 12.5 % sucrose, 
and overnight at 4"C in blocking solution modified to contain 25 % sucrose. 
Infiltrated embryos were mounted in Tissue-Tek  O.C.T. compound (Miles 
Laboratories, Elkhart, IN), frozen in liquid nitrogen, and either immedi- 
ately sectioned or stored at  -85°C. 
Frozen sections of 10 ttm thickness were cut at  -26°C,  collected on 
slides, washed in PBS for 5 rain at room temperature, incubated for 10 min 
at room temperature in 90% methanol containing 3% hydrogen peroxide 
to inhibit endogenous peroxidases, and incubated in blocking solution for 
60 rain at 37"C. Anti-sera were diluted 1:500 and m_Ab  hybridoma superna- 
tants were diluted 1:5 in blocking solution; and sections were incubated with 
the diluted antibodies overnight at 4"C. After four washes of 30 rain each 
in PBS containing 0.1% Triton X-100 at room temperature with agitation, 
sections were incubated with a biotinylated secondary antibody, either goat 
anti-rabbit or horse anti-mouse IgG as appropriate, for I h at room temper- 
ature, and then washed as above and incubated 60 rain at room temperature 
with an avidin-horseradish peroxidase complex in PBS prepared according 
to manufacturer's specifications (Vectastain Elite Kit; Vector Laboratories, 
Burlingame, CA). Antibody binding was detected by developing the slides 
for 0.5-2 rain at room temperature using diaminobenzidine  as substrate. Af- 
tcr a short wash in water, the slides were mounted under a cover glass in 
PBS containing 90% glycerol. For double labeling, sections stained for a 
MRF with the horseradish peroxidase system were further incubated in a 
1:5 dilution of anti-MHC  rnAb F59 hybridoma supernatant,  washed as 
above, incubated for  1 h  at room temperature in 0.5  ~g/ml fluorescein- 
conjugated goat anti-mouse IgG (heavy and light) and mounted under glass 
coverslips in 75% glycerol in PBS containing 2.5%  1,4-diazabicycio  [2, 2, 
2] octane to retard fluorescence bleaching. As a control, primary antibodies 
were omitted from selected sections on a slide. No nuclear staining was ob- 
served in these controls, rather there was a brownish stain that was uniform 
throughout the section, with the intensity of  the background increasing with 
increased time of incubation with substrate. The epidermis was nonspe- 
cifically stained in sections analyzed for myogenin; this staining was also 
seen when the anti-myogenin mAb was omitted and was thus due to the anti- 
mouse secondary reagents. Unless noted otherwise, the results reported be- 
low were reproducibly obtained with at least four independently prepared 
embryos. 
Results 
We used immunohistology to analyze MRF expression pat- 
terns in the somites of early postimplantation mouse em- 
bryos. In mice, the first, most rostral, somites form on em- 
bryonic day 8 (E8), and additional somites continue to form 
until the most caudal of the approximately 60 pairs of so- 
mites appears in the tail on E12-13. Thus, the rostral-caudal 
position of a somite reflects its age, with rostral somites be- 
ing developmentally older than caudal somites.  A  somite 
forms as an epithelial ball which soon subdivides into der- 
matome, myotome, and sclerotome. For immunohistochem- 
ical assays of MRF proteins, we used the specific antibodies 
described by Smith et al. (1993). We addressed the following 
questions:  (a) At what stages of somite development and 
where within a somite is each MRF protein initially detect- 
able? (b) Do the MRFs have similar or distinct patterns of 
expression within a somite? (c) What is the relationship be- 
tween myocyte differentiation and expression of individual 
MRFs? 
Initial Stages of  MRF Protein Expression in Somites 
To determine the stage of somite development at which each 
MRF was initially expressed, we first determined which so- 
mites defined the rostral and caudal limits of expression of 
each MRF in embryos at different stages of development (not 
shown). The youngest embryos examined,  E8.5, contained 
seven pairs of epithelial stage somites, and none of these so- 
mites contained cells that stained with anti-MRF antibodies. 
In E9 embryos (13-19 somite pairs), Myf-5, myogenin, and 
MRF4 were each expressed in the most rostral somites, but 
had different caudal limits of expression.  In 16 somite em- 
bryos, for example, cells that expressed Myf-5 and myogenin 
were found in the 9-10 most rostral somites,  whereas cells 
that expressed MRF4 were found in only the 3-4 most rostral 
somites.  No cells were found to express MyoD in embryos 
with ~<19 somite pairs. 
In E9.5 (24-28  somite) embryos,  Myf-5, myogenin, and 
MRF4 had rostral and caudal limits of expression that were 
similar to those in E9 embryos. For all of the E9-E9.5 em- 
bryos  examined,  the number of unstained caudal  somites 
was approximately six for both Myf-5 (range 5-7, n =  6) and 
myogenin (range 5-11, n  =  ll), and ~11  for MRF4 (range 
10-13, n =  5). Cells that expressed each of these three MRFs 
were found in all of the more rostral somites, i.e., from so- 
mite 1 to the somite defining the caudal limit of expression 
for that MRF. At E9-9.5, the caudal limits of Myf-5 and myo- 
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mites  in which the epithelium  was transforming into der- 
mamyotome and sclerotome. 
Unlike younger embryos in which MyoD was not detected, 
nuclei that stained with the anti-MyoD serum were detected 
in embryos with >120 somites.  An unexpected finding was 
that  somites  that  did  not contain  MyoD  ÷ nuclei  were,  at 
certain stages, interspersed among those that did. In one 23 
somite embryo, for example, somites 1, 2, and 3 contained 
3,  7,  and  2  MyoD  ÷ nuclei  respectively;  somites  6  and  9 
each contained 1 MyoD  ÷ nucleus, and somites 11,  12,  and 
13  contained  1,  2,  and  1 MyoD  ÷ nuclei  respectively.  All 
other somites in this  embryo did not have MyoD  ÷ nuclei. 
Similar discontinuous MyoD expression was seen in the two 
26  somite  embryos  that  we  examined.  The  number  of 
MyoD  ÷ nuclei  generally was highest  in trunk  somites.  In 
one 29  somite embryo,  for example,  MyoD  ÷ nuclei  were 
observed in each of somites numbers  1-15, but the largest 
number of stained nuclei, 21, was in somite 12, whereas ~<8 
stained nuclei were in somites 1-10. In El0.5 embryos, the 
MRFs no longer had the clearly different caudal limits of ex- 
pression which were seen at E9.5, rather each MRF was ex- 
pressed in about the same number of somites.  In embryos 
with 35-36 somites, for example, each MRF was found in 
all but the most caudal 4-5 somites. 
In accord with the finding that all except the most caudal 
5-7 somites expressed Myf-5 in E9-9.5 embryos, the earliest 
stage of somite development at  which  Myf-5  ÷ cells  were 
detected was when the sclerotome was first forming. In the 
somite stained with Myf-5 serum shown in Fig.  1 A, for ex- 
ample,  the  sclerotome was  forming in the ventral-medial 
comer, but the columnar epithelium still  extended most of 
the way around the somite. Two Myf-5  ÷ cells were found in 
the section shown (Fig. 1 A), and serial sections showed that 
this entire somite had only three Myf-5  ÷ cells. Such a small 
number of Myf-5  ÷ or myogenin  ÷ cells (~<15) was typical of 
the two or three most caudal of the somites with MRF ex- 
pression. 
Additional  analyses  showed that Myf-5 expression  pre- 
cedes myogenin expression by a brief period. Because Myf-5 
and  myogenin were  expressed  in  approximately the  same 
number of somites,  it appeared that both must accumulate 
to detectable levels at almost the same developmental stage. 
In analyses of multiple serially sectioned embryos, however, 
we failed to find myogenin  ÷ cells in somites as immature as 
those  which  contained  Myf-5  ÷ cells.  Rather,  the  caudal- 
most somites with myogenin  ÷ cells had well formed derma- 
tomes and sclerotomes (Fig.  1 D).  To confirm that Myf-5 
was expressed prior to myogenin, we serially sectioned four 
E9.5 embryos and stained alternate sections with the anti- 
Myf-5 serum and anti-myogenin mAb (not shown). In each 
of the four embryos, there was at least one somite with Myf- 
5-expressing nuclei that was located caudal to the first  so- 
mite with myogenin-expressing nuclei. Because more caudal 
expression implies earlier expression, these results suggest 
that the first MRF protein detectable by immunohistology in 
somites is Myf-5, which soon is followed by myogenin, then 
by MRF4,  and finally by MyoD. 
MRF Proteins and Subdomains of Individual Somites 
We next found that, within a single somite, there were sev- 
eral differences among the expression domains of the MRFs. 
One difference was in the extent of expression along the dor- 
sal-ventral axis of a somite. This difference was apparent at 
early stages of somite development among the small number 
of Myf-5  ÷ and  myogenin  ÷ cells  in  the  three  or four most 
caudal  of the  MRF-expressing  somites.  In  such  somites, 
transverse  sections  showed that the  Myf-5  ÷ cells  were lo- 
cated in the most dorsal portion of the somite nearest the 
neural  tube  (Figs.  1,  A-C,  and  2 A  and B),  whereas  the 
myogenln  ÷ cells were found in both the dorsal and ventral 
Figure 1. Initial stages of Myf-5 and myogenin expression. Serial transverse sections of E9-9.5 embryos were stained with anti-Myf-5 
serum (A-C) or anti-myogenin mAb (D), and the most caudal somites which expressed a particular MRF were identified. (A) In a 13 
somite embryo, the most caudal somite with Myf-5  ÷ cells (somite number 6/7) was immature, as it had a columnar epithelium that still 
extended most of the distance around the somite. (B and C). Myf-5 was initially expressed near the neural tube in the dorsal-most portion 
of the somite, as shown by an oblique section through somite 4/5 of a 13 somite embryo (B) and a transverse section through somite 
16/17 of a 24 somite embryo (C) (see also A). (D) In contrast to Myf-5, myogenin was initially expressed in cells located throughout 
the dorsal-ventral extent of the myotome (cf. Fig. 2).  In a different 13 somite embryo, the most caudal somite with myogenin  ÷ cells 
was relatively mature, as it had a columnar epithelium that was limited to the region of the dermamyotome. Thus, Myf-5 was initially 
expressed at an earlier stage of somite development than myogenin (see text). Dorsal up.  Bar, 50/~m. 
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Figure 2.  Myf-5 and myogenin are initially expressed in the ante- 
rior portion of a somite. Sections of E9 (13 somite) embryos were 
made and stained with the Myf-5 antiserum (A) or myogenin mAb 
(B).  (A) Frontal  sections,  with  anterior  to the left,  showed that 
Myf-5  ÷ cells (arrows) were located in anterior portions of somites 
at this  stage• A section through  somites numbers 4,  5,  and 6 is 
shown• The slightly oblique plane of section was through the dor- 
sal halves of the somites shown above the neural tube, and through 
the  ventral  halves of the  contralateral  somites  shown below the 
neural  tube.  The Myf-5  + cells  (arrows) were  found only  in the 
dorsal halves of somites, near the neural tube (cf. Fig. 1, B and C). 
(B) Myf-5 and myogenin are initially most abundant in the anterior 
halves of somites;  and Myf-5, but not myogenin, is also initially 
restricted to the dorsal region of a somite. Diagrams are based on 
reconstructions  from serial transverse sections through two 13 so- 
mite embryos that were stained for either  Myf-5 or myogenin as 
indicated. Each vertical dotted line represents a single section and 
each black dot represents the location  of a MRF-expressing  cell 
along  the  dorsal-ventral  axis of the  somite  as determined  from 
photographs  or camera lucida  drawings.  Missing  sections  were 
either lost during processing or used as no antibody controls.  So- 
mites numbers 4/5 and 5/6 are diagrammed.  Photographs  of sec- 
tions labeled 1B and 1D are shown in the corresponding panels of 
Fig.  1. Bar, 50/~m. 
halves (Figs.  1 D  and 2 B).  In addition,  at this early stage 
of development,  Myf-5  ÷ cells  were most abundant  in  the 
anterior portion of the somite, as shown by a frontal section 
stained for Myf-5 (Fig.  2 A). Analyses of serial transverse 
sections,  as  diagrammed  in  Fig.  2  B,  showed  that  myo- 
genin  ÷ cells were similarly more abundant  in  the anterior 
portions of somites at this stage. 
The  dorsal-ventral  differences  in  MRF  expression  do- 
mains  were  further  analyzed  in  E9.5  (24-28  somite)  and 
El0.5  (34-37 somite) embryos. In E9.5 embryos, the fore- 
limb  bud  somites,  numbers  8-13,  that  were  analyzed  in 
greatest detail  have well  formed dermatomes,  myotomes, 
and sclerotomes. In serial transverse sections of E9.5  em- 
bryos,  these  somites had  Myf-5  ÷ cells  that  were  found  in 
only the dorsal-most 50-60 % of the somites (Figs. 3 A and 
4).  MRF4  + cells appeared to  occupy a  larger region,  ex- 
tending  through  most of the  myotome (Figs.  3  E  and 4). 
Myogenin  + cells  were  more  numerous  than  MRF4  ÷ cells 
and  appeared to  extend throughout the  full dorsal-ventral 
length  of the  myotome (Figs•  3  D  and  4).  Surprisingly, 
MyoD  + cells were differently distributed in neck and trunk 
somites  in  23-26  somite  embryos.  The  MyoD  ÷ cells  in 
neck somites were found only in the dorsal half of the somite 
(not  shown),  whereas  the  MyoD  ÷ cells  in  trunk  somites 
numbers 11-13 were found only in the ventral half of the so- 
mite (Figs. 3, B and C, and 4). An example of a control assay, 
in which the primary antibody was left out, is shown in Fig. 
3 F. In this example, and in all other such control assays, no 
myotomal cells were stained above background. 
To  confirm  the  distinct  dorsal-ventral  distributions  of 
Myf-5 and myogenin expression within somites, we serially 
sectioned E9.5 embryos and stained sections alternately with 
the anti-Myf-5 serum and the anti-myogenin mAb. As shown 
in Fig. 5, this staining of alternate sections demonstrated that 
myogenin-expressing nuclei were found in ventral regions of 
the myotome that lacked Myf-5-expressing nuclei. The dis- 
tinct expression patterns  were found in both neck somites 
(e.g., somite 9/10;  Fig. 5, A-C) and trunk somites (e.g., so- 
mite 11/12, Fig.  5, D-F). 
The  distinct  dorsal-ventral  patterns  of MRF  expression 
seen in neck and trunk somites of E9.5 embryos were par- 
tially recapitulated in hindlimb bud and tail somites of El0.5 
embryos  (not  shown).  In  the  most  caudal  of the  MRF- 
expressing  somites  (i.e.,  tail  somites  numbers  30-31)  of 
35-36 somite embryos, Myf-5 was expressed in the dorsal 
half of the somite and myogenin was expressed throughout 
the myotome as in E9.5  embryos.  Unlike the somites at a 
similar stage of development in E9.5 embryos, however, the 
El0.5 tail somites also expressed MRF4 and MyoD, with the 
MRF4  + cells located mostly in the dorsal myotome and the 
MyoD  ÷ cells located mostly in the ventral somite. In El0.5 
embryos, these distinct  dorsal-ventral  MRF patterns were 
found in only two or three tail somites. 
The forelimb somites of El0.5 embryos had different MRF 
expression patterns than either El0.5  tail  somites or E9.5 
forelimb somites (Fig. 6). In contrast to its restricted expres- 
sion in E9.5 forelimb and El0.5 tail somites, MyoD was ex- 
pressed throughout the myotomes of El0.5 forelimb somites, 
though staining was more intense in the ventral portion of 
the somite (Fig. 6 D). MRF4  + cells were also found through- 
out the myotomes of these somites, though the MRF4  ÷ cells 
in the most ventral regions of the  trunk  somite myotomes 
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sections of forelimb bud somites (numbers  11 or 12) were stained with the different anti-MRF antibodies as indicated in A-E. F shows 
an example of a control assay; the control section was from the same embryo as in C and was processed identically except that the anti- 
MyoD antiserum  was omitted.  Black arrows point  to some of the  MRF-expressing  nuclei in each section and also indicate the dor- 
sal-ventral extent of cells in the myotome that expressed each MRF. The white arrow in A indicates two cells in the presumptive sclerotome 
that stained with the Myf-5 antiserum.  At this developmental  stage in these somites,  (A) Myf-5  + cells were only in the dorsal somite; 
(B and C) MyoD  ÷ ceils were only in the ventral somite, though, in contrast to the forelimb bud somites shown here,  MyoD  ÷ cells were 
in the dorsal half of neck somites (see text); (D) myogenin  + cells extended throughout the dorsal-ventral  extent of the myotome; and (E) 
MRF4  ÷ cells extended farther ventrally than Myf-5  ÷ cells but not as far as myogenin  ÷ cells. See Fig. ,~ for additional data.  Bar, 70 #m. 
were fewer in number and much more weakly stained than 
those  in  dorsal  myotomes (Fig.  6  C).  In addition,  many 
fewer  Myf-5  ÷  cells,  usually  <10  per  somite  and  very 
weakly stained, were found in El0.5 forelimb somites than 
in El0.5 tail somites or E9.5 forelimb somites (Fig. 6 A). The 
Myf-5  ÷ cells were found throughout the myotomes, though, 
due to the small number of stained cells, individual sections 
(e.g.,  Fig.  6 A) showed no stained cells or a more limited 
distribution.  Cells that expressed myogenin and MHC were 
found throughout the dorsal-ventral extent of the myotomes 
in El0.5 forelimb somites. 
A second striking difference among MRF expression pat- 
terns was that Myf-5 and MyoD, but not myogenin or MRF4, 
were expressed by ceils in the dermatome. In sagittal sec- 
tions,  the columnar epithelium of the dermatome has the 
shape of a shallow bowl, with the nuclei of myotomal cells 
lying between the lips of the dermatome. In MRF-expressing 
neck, forelimb bud, and trunk somites of E9-9.5 embryos, 
Myf-5  + cells were found in dorsal myotomes (cf. Figs. 3 A 
and 5 A), in dorsal regions of the anterior and posterior lips 
of the dermatome (Fig.  7 A), and in the dorsal-medial lip 
of the dermatome,  nearest the  neural  tube (Fig.  5  F).  In 
El0.5 embryos, the few Myf-5  ÷ cells that remained in these 
same  somites  appeared  to  be  restricted  to  the  myotome. 
Though the few MyoD  ÷ cells in E9.5 embryos were only in 
myotomes, El0.5  embryos had  many MyoD  ÷ cells  in  the 
anterior and posterior lips of the ventral dermatome in the 
trunk somites (Fig. 7 D), and a few in the dorsal dermatome 
in  the  neck  somites.  Myogenin  ÷ and  MRF4  + cells  were 
found only in myotomes at all developmental stages exam- 
ined (Figs.  7, B  and C). 
A final difference among the MRF expression patterns was 
that a few cells in what appeared to be the sclerotome stained 
with the anti-Myf-5 serum, but not with antibodies to the 
other MRFs. In E9.5 embryos, a small number of cells (x<5 
per  somite)  that  stained  with  the  Myf-5  antiserum  were 
found in the ventral-medial region of the somite, well within 
the presumptive sclerotome and separated by three or four 
cell diameters from the layer of ceils that form the myotome 
(Figs. 3 A and 4). Such cells were found in six different era- 
Smith el al. Somites, Myogenesis, and MRF Proteins  99 Myf-5  Anterior 
,  .  .......  ~~.~  ~.:.'..~  ~ ~::~,~:~  ~..~ 
~:",  ~  ~''~'''::t'':'~''.,,-,~-:,:--,,'::~  '::~:':~',,,tS.:i 
~  ~,1 ~j.  l|j.l&il~.:~:  :  : ~#1  tel,  I:  :  :  : 
',:'-,"  ,  ."  :,,"  r.~  .',,:',',:!  i!!l~i  ! 
11/12  10111  12/13 
Myogenin 
~~ii!:  ~!ili!!ili!ii!~  ii!!il  i!i!i!~ 
~~.:  :  ',  ',  :  :  ~  :  ~,'.~t~,  :  :  :  :~.:  :  :  :  ,°:  ;.~  :  :  :~i~ 
'  '  '  *  ......  ::¥ .....  *  ~I  ....  :::::  ~  IlY'  :  9 :  ',  :  :.~  :  :  ,  99~4,,  .  .....  ~  ......  Ilo  .....  :... 
~~...'  i H_~ ~:,, i, .I.~ : : .... :~., : .. : : .~  |I~: ,, ,, :~ 
:::::::::::::::::::::::::::::  4, ;.~ :  :  :  ,.~':" 
:::::::::::::::::::::::::::  !~  r  :  :  :  ~..'~ 
~.~."  :' ! '~  ! ! ~', |d.~:  '. : '. :~:  : :  : ~t  ~S:  '. '. :  :~ 
,,  o*  ,,,,,  ,,  .......  :~*~  ~~I:::::~.','.,~08~.~  .....  ~  .....  ~  ,~*,,.~.:: 
::  ii~  "~;"i:i::  i:::'~  81::i.~i  ~ 
':t~'r  tl ..........  O  .....  :  ....  t  :::::  :::::  j  :::::..,  .........  ,,.  .....  .~.,,  ...........  ._  ~ ...... 
12/13  11/12  10/11 
MRF4 
:":  :::"::::i~i::"":::"  :":::~'":  ::::::::::: 
i!  iii  'ii  ".  .~  i  i  !i'~  !  ,  !~;  !!i 
..........  ~  .........  i~,,  '~°  ~'8 .... 
::1  ::8|',:::~  ::::::i  ::::::~::  ::~i,*~:::: 
:::  ~:~0|:::~.  ::::,~i  :::::~::  :~rlg:::: 
,::  :9191::',~  ,,::~.|  ,,:,,.'~,,  .*)*~.:I,:,, 
:~i~!  i~i~i!il  ~  iii.*.~il  iiiii~il  i.i!ii.ii! 
:i:..:  ..... :.-"":..."~:....:~:  :~.--:,i~:":  :~:  ............  i.:i..:~-.-"~:  -"....:.".-.:....:.i:.~...:..~.,..i~  ~;,.!....: 
12/13  11/12  10/11 
MyoD 
12/13  11/12  10/11 
Figure 4. Distributions of MRF-expressing cells within three adja- 
cent somites. Serial transverse sections through the forelimb bud 
region of E9.5 embryos were prepared, and all sections from a sin- 
gle embryo were stained with one of the anti-MRF antibodies. As 
in  Fig.  2,  the diagrams,  which were reconstructed  from photo- 
graphs or camera lucida drawings,  show the  locations  of MRF- 
expressing  cells  within  adjacent  somites.  Small  circles  in  the 
Myf-5 somites represent positive cells in the presumptive sclero- 
tome (cf.  Fig.  3 A).  The numbers below each diagram give the 
number of the somite which was examined. 
Figure 5.  Distinct  dorsal-ventral  distributions  of myogenin and 
Myf-5 within single somites. Serial transverse sections of E9.5 em- 
bryos were made, and those through the left side of neck somite 
9/10  (A-C) and  the  right  side of trunk  somite  11/12 (D-F) are 
shown. As indicated, every other section was stained with the anti- 
Myf-5 serum,  and the remaining alternate sections were stained 
with the anti-myogenin mAb.  Arrows indicate  some of the cells 
that express each MRF, as well as the dorsal-ventral extent of the 
MRF-expressing  cells  within  the  myotomes.  The  myogenin- 
expressing cells extended farther ventrally than the Myf-5 express- 
ing  cells.  Also  indicated  are  the  neural  tube  (n);  presumptive 
sclerotome (s); and forelimb bud (fib). Bar,  70 #m. 
bryos that were examined,  but were not found in every so- 
mite within a  particular embryo. In one 26 somite embryo, 
for example, four pairs of somites in the forelimb bud region 
were examined in serial transverse sections, and three out of 
the eight somites were found to contain cells in the sclero- 
tome that stained with the anti-Myf-5 serum.  In El0.5  em- 
bryos, we did not observe cells in sclerotomes that stained 
with the anti-Myf-5  serum. 
MRFs and Myosin 
Previous analyses by immunofluorescence showed that myo- 
cytes which  formed from early  somite cells  in vitro could 
contain  MHC  in the absence of detectable  levels of any of 
the four MRFs  (Cusella-De  Angelis  et al.,  1992;  Smith et 
al.,  1993). Because the immunoperoxidase detection system 
used  here  was  more  sensitive  than  immunofluorescence, 
we  reinvestigated  MRF  and  MHC  expression  in myocytes 
formed  from  somite cells.  Cells  were  cultured  from E8.5 
somites (Smith et al.,  1993) and, after three days of culture, 
the  cells  were  stained  simultaneously  with  mAb  F59  fol- 
lowed by fluorescein-conjugated  goat anti-mouse  IgG and 
with an anti-MRF followed by the immunoperoxidase system. 
Though the peroxidase system did give stronger nuclear sig- 
nals than  fluorescence,  the staining  patterns,  including  the 
The  Journal  of  Cell  Biology,  Volume  127,  1994  100 Figure 6. MRF and MHC protein expression in trunk somites of El0.5 embryos. Transverse sections of trunk somites numbers 11 or 12 
of El0.5 embryos were stained with the anti-MRF antibodies or anti-MHC mAb as indicated. Arrows indicate regions containing cells 
that stained with a particular antibody. At this stage, myotomes in trunk somites extend farther ventrally than those in more rostral somites; 
the open arrowheads indicate where the ventral myotome  borders would be in somites numbers 8, 9, or 10. The myogenin  and MHC antibod- 
ies stained ceils strongly throughout the dorsal-ventral extent of the myotome. The MRF4 antibody stained cells strongly in the dorsal 
myotome, but weakly in the ventral myotome; whereas the MyoD antibody showed the reverse pattern, with more staining in the ventral 
than dorsal myotome. Bar, 100 #m. 
presence of myocytes that stained with anti-MHC but not 
anti-MRF,  were similar with both methods. 
To examine the relationship between MRF expression and 
myocyte differentiation,  we first determined which somites 
defined the rostral and caudal limits of MHC expression in 
embryos of different ages. In E9.5 embryos, MHC expres- 
sion was found in all rostral somites, but was not detected 
in ,x, ll (range 10-13, n =  5) of  the most caudal somites; thus, 
MHC was expressed in more somites than MyoD, about the 
same number of somites as MRF4, and in fewer somites than 
Myf-5 or myogenin. MHC staining in E9.5 myocytes was 
filamentous but not striated; and staining at the ends of myo- 
cytes often showed swellings  and bifurcations (Fig.  8 B). In 
El0.5 embryos, MHC was expressed in all but the five or six 
most caudal somites, which was about the same number of 
somites as expressed the four MRF proteins at this stage. 
In myotomes, each of the four MRFs was expressed both 
by MHC  ÷ myocytes and by cells that did not express MHC. 
Double labeling showed that cells in the most dorsal regions 
of myotomes expressed one or more MRFs but not MHC. 
Such cells  were  found by  E9  for myogenin,  Myf-5,  and 
MRF4,  and by El0 for MyoD. Examples of cells that ex- 
pressed MRF4, but not MHC, are shown in Fig.  8.  These 
presumptive myoblasts were located in a hemispherical or 
triangular region on the dorsal edge of the myotome. MHC  + 
myocytes were found in a band beginning just ventral to the 
presumptive myoblasts (Fig.  8).  Forelimb bud somites in 
E9.5 embryos contained no more than 30 or 40 myocytes 
which were found in only the dorsal half of the somite (not 
Figure 7. Cells that expressed Myf-5 and MyoD, but not myogenin 
or MRF4, were found among the columnar epithelial cells of the 
dermatome. Sections through forelimb bud somites of E9.5 (Myf-5, 
myogenin,  and MRF4) or El0.5 (MyoD) embryos were stained with 
the anti-MRF antibodies as indicated. Large arrows indicate ceils 
in the lips of dorsal dermatomes that were stained with the Myf-5 
antibody (see also Fig. 5 F) and ventral dermatomes that were 
stained with the MyoD antibody, Cells in both the anterior and 
posterior lips of the dermatome stained with Myf-5 and MyoD, 
though, in the figure shown, only the posterior  lip has MyoD  + 
cells. Small arrows in each panel indicate cells in the myotomes  that 
stained with a particular antibody. Sections were through the dorsal 
half of the somite for Myf-5, myogenin, and MRF4, and through 
the ventral half of the somite for MyoD. Anterior is to the left. Bar, 
40 #m. 
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MRF4. A single sagittal section of trunk somite number 13/14 of 
an E9.5 embryo was doubly stained with the anti-MRF4 mAb and 
peroxidase for light microscopy (,4) and with the anti-MHC mAb 
for fluorescence  microscopy  (B).  Arrows  indicate presumptive 
myoblasts in the dorsal region of the myotome that stained with the 
MRF4, but not the MHC, antibody. Arrowheads indicate myocytes 
that both expressed MHC and contained MRF4-expressing nuclei. 
Nuclei in all myocytes appeared to contain MRF4. Bar, 30/zm. 
shown), whereas the same somites in El0.5 embryos con- 
tained many more myocytes which were found throughout 
the dorsal-ventral extent of the myotome (Fig. 6 E). Though 
it was sometimes difficult to assign a particular nucleus to 
a  particular myocyte, it appeared that all myocytes at the 
forelimb bud region of E9.5 embryos expressed myogenin, 
and perhaps Myf-5 and MRF4 as well. As an example, myo- 
cytes with MRF4-expressing  nuclei are  shown  in  Fig.  8. 
Consistent with MyoD appearing after MHC, the myocytes 
in E9.5 embryos failed to express MyoD, whereas myocytes 
in El0.5 embryos did express MyoD. In the most rostral so- 
mites at E9.5 (i.e., somites 1-2), some myocytes failed to ex- 
press Myf-5. Nuclei in myocytes  tended to be ovoid, whereas 
those in presumptive myoblasts tended to be round. In E9.5 
embryos, the ventral border of the band of myocytes was 
close to the ventral limits of Myf-5 and MRF4 expression. 
By doubling  labeling  (not  shown),  myogenin  ÷ cells  were 
observed that  lay  ventral,  as  well as  dorsal,  to the myo- 
cytes, whereas Myf-5  ÷ cells were not found ventral to the 
myocytes. 
Discussion 
By immunohistology, we found that the four muscle regula- 
tory  factor proteins  are  expressed in  distinct  patterns  in 
mouse  somites.  Dermatome,  myotome,  and  sclerotome 
cells, as well as the dorsal and ventral halves of somites, had 
transiently different staining patterns with each MRF anti- 
body. Because cells in different regions of a somite express 
the MRFs in different patterns, it seems likely that myogenic 
cells in the somites have multiple sites of origin and form via 
multiple molecular pathways. 
MRF proteins first accumulate in the anterior half of a so- 
mite at about the time the sclerotome begins to form. The 
Myf-5 protein was found in somites before formation of the 
dermamyotome and  was  initially detectable in  only dor- 
sal-anterior cells.  Because the three or four most recently 
formed somites may contain Myf-5 mRNA (Ott et al., 1991) 
but not detectable Myf-5 protein, it appears that a few hours 
could be required for the Myf-5 protein to accumulate to a 
detectable  level.  Accumulation  of the  myogenin protein, 
which appears to occur shortly after Myf-5, also was de- 
tected first in anterior cells,  though myogenin  + cells were 
not additionally restricted to the dorsal half as were Myf-5  ÷ 
cells. These results are consistent with studies showing that 
the anterior and posterior halves of somites have distinct mo- 
lecular and functional properties (Stern and Keynes, 1987), 
and that the muscle-specific expression of desmin, though it 
begins later than Myf-5, also initiates in dorsal-anterior cells 
(Kaehn et al.,  1988). At later stages, MRF expression pat- 
terns in anterior and posterior halves of somite become iden- 
tical. 
To the extent that MRF expression is a marker for commit- 
ted myogenic cells, the MRF expression patterns in the der- 
matomes suggest that myogenic cells originate at sites in ad- 
dition to the dorsal-anterior region of the somite. Though 
Myf-5 is initially expressed only in the dorsal-anterior so- 
mite,  it is later expressed by cells in all lips of the dorsal 
dermatome,  suggesting  that  myogenic  cells  arise  in  the 
posterior,  as  well as the anterior, half of the dermatome. 
Also, in specific somites, MyoD is expressed in both the an- 
terior and posterior lips of the ventral dermatome. The ulti- 
mate fates of the MyoD- and Myf-5-expressing cells in the 
E9.5 dermatomes are unknown, though it is known that ei- 
ther MyoD or Myf-5 must be expressed for myoblasts to 
form (Rudnicki et al.,  1993). Dermatomal cells likely enter 
the myotome as  myoblasts and form myocytes, consistent 
with the idea that the dermatome is a continuing source of 
myogenic cells during somite development (Milaire,  1976; 
Ordahl,  1993). 
The MRFs are expressed in different patterns in dorsal and 
ventral somites, and the myogenic cells in these regions may 
thus arise via distinct molecular pathways.  In particular, cells 
in the dorsal dermatome express Myf-5, whereas cells in the 
ventral dermatome express MyoD,  suggesting  that Myf-5 
and MyoD expression are under different controls in the dor- 
sal and ventral halves of a trunk somite. Because previous 
work  showed  that  mice  with  an  inactivated  myoD  gene 
formed muscles normally but had abnormally high Myf-5 
levels (Rudnicki et al.,  1992), it is possible that Myf-5 ex- 
pression spreads to the ventral dermatome in the absence of 
MyoD. Previous work also showed that myogenic cells in the 
limb bud and visceral arches express the MRF mRNAs in 
different sequences than cells in the somites (Ott et al., 1991; 
Hinterberger et al.,  1991) and that, in culture, somite cells 
express a different pattern of MRF proteins than limb bud 
cells (Smith et al., 1993). Because individual MRFs appear, 
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genes (Brelman et al.,  1990;  Miller,  1990;  Yutzey et al., 
1990;  Block and Miller,  1992;  Braun et al.,  1992),  the 
different sequences of MRF expression in the somites could 
lead to distinct muscle cell phenotypes. 
Neck and trunk somites differ in structure and MyoD ex- 
pression. In structure, the myotomes and dermatomes of El0 
trunk somites (i.e.,  beginning with and caudal to somite 
number 11) extend ventrally farther than those of more ros- 
tral somites. This size difference can be clearly seen in the 
expression patterns of myogenin promoter-/acZ and desmin 
promoter-/acZ fusion genes in El0.5 transgenic mice (Cheng 
et al., 1993; Yee and Rigby,  1993; Li et al., 1993).  Somite 
11 appears to be the most rostral somite involved in rib for- 
marion, so the ventral extensions of the myotomes may con- 
tribute to the formation of intercostal muscles. These struc- 
tural differences may arise due to different patterns of cell 
death, as seen in the corresponding somites in chickens (Tos- 
ney, K. W.  1994. J.  Cell Biochem.  188[Suppl]:462a).  The 
MyoD protein first accumulates in the dorsal myotome of 
neck somites, but in the ventral myotome and dermatome of 
trunk somites. The Pax-3 mRNA also appears to accumulate 
in the ventral regions of trunk somites (Bober et al.  1994; 
Williams and Ordahl,  1994;  Goulding et al.,  1994).  Thus, 
as is the case for myogenin (Cheng et al.,  1993;  Yee and 
Rigby,  1993),  expression of MyoD, and perhaps the other 
MRFs, is likely to be controlled by different mechanisms in 
dorsal and ventral regions of neck and trunk somites. 
An  unexpected finding was  that the  anti-Myf-5 serum 
stained a  few cells in the presumptive sclerotome of E9.5 
forelimb bud somites. This result raises the possibility that 
the  rib-deficient phenotype seen  in  mice  without Myf-5 
(Braun et al., 1992) is due to loss of Myf-5 expression in the 
sclerotome. Myf-5 mRNA, however, has not been reported 
in sclerotome cells, though transient expression in a few ceils 
may not be apparent by in situ hybridization. Possible ex- 
pression of Myf-5 in the sclerotome thus requires confirma- 
tion, for example by use of independent anti-Myf-5 sera or 
additional in situ mRNA analyses. 
By El0.5,  differences in MRF expression patterns were 
found in only the two or three most caudal of the MRF- 
expressing somites.  In the more rostral somites at El0.5, 
each of the MRFs was expressed throughout the myotome, 
though Myf-5 was expressed by far fewer cells in the more 
rostral somites than in the more caudal somites. Also, in 
El0.5 embryos, MRF4, MHC, and MyoD were expressed in 
about the same numbers of somites as Myf-5 and myogenin, 
rather than in fewer somites as in E9.5 embryos. Thus, myo- 
genesis appears to occur more rapidly in somites which form 
later in development. 
All somiric myocytes appeared to express myogenin, and 
likely one or more of the other MRFs. A previous study sug- 
gested that at least some myocytes in E9.5-10.5  somites ex- 
pressed  MHC,  but  not the  myogenin or  MyoD proteins 
(Cusella-De Angelis et al.,  1992).  In  E9.5  embryos,  we 
found myocytes  that failed to express MyoD, a result that was 
expected because MyoD is expressed after MHC. In contrast 
to Cusella-De Angelis et al. (1992), however, we detected the 
myogenin protein more than one day earlier in development 
and the myocytes that we observed in E9-9.5 embryos did 
express myogenin. Because both groups used the same anti- 
myogenin mAb, the different results were likely due to differ- 
ent fixation conditions or the higher sensitivity of the peroxi- 
dase system compared to fluorescence. In addition, with the 
exception of a subgroup of myocytes in the most rostral so- 
mites that failed to express Myf-5, the myocytes in E9.5 em- 
bryos appeared to express MRF4 and Myf-5 in addition to 
myogenin. Thus, though it is possible that we missed critical 
somites or developmental stages, we did not find evidence 
of  myocytes in vivo that differentiated in the absence of MRF 
expression. The origin of the MRF-/MHC  + myocytes in so- 
mite cell cultures (Cusella-De Angelis et al., 1992; Smith et 
al.,  1993; this work), therefore, remains unclear, though it 
is likely that they are descendants of cells that previously ex- 
pressed  MRFs.  Our  results  also  showed,  as  in  cultures 
(Smith et al.,  1993),  that each MRF is expressed in both 
myocytes and myoblasts. 
Though immunohistology  uncovered aspects of MRF pro- 
tein expression that were not anticipated from in situ hybrid- 
ization studies, the expression patterns of the MRF mRNAs 
are consistent with the overall expression patterns of the 
MRF proteins. In rodents, Myf-5 mRNA is the first detect- 
able MRF mRNA and is followed in sequence by the myoge- 
nin, MRF4, and MyoD mRNAs (reviewed by Buckingham, 
1992).  The MRF proteins appeared in the same sequence, 
and each MRF protein was first detectable within a few hours 
of the first appearance of its mRNA. The first MRF mRNAs 
to be expressed are found in the dorsal-medial region of epi- 
thelial stage somites (Ott et al., 1991; Pownall and Emerson, 
1992).  Similarly, the Myf-5 protein was first detectable in 
the dorsal half  of somites before full separation of the sclero- 
tome and dermamyotome. Also,  in the neck somites, the 
Myf-5 mRNA and protein both become less abundant by 
El0.5. Additional aspects of a MRF protein expression that 
were revealed by the single cell resolution of immunohis- 
tology included initial expression in the anterior half of a 
somite and the different expression patterns in dorsal vs. 
ventral somites, neck vs.  trunk somites, and myotome vs. 
dermatome and sclerotome. 
Some limitations of the assay must be kept in mind when 
interpreting MRF antibody staining patterns. First, because 
MRF function is modulated by phosphorylation and interac- 
tions with additional proteins  (reviewed by Olson,  1992; 
Weintraub, 1993),  the presence of a MRF protein in a cell 
does not necessarily indicate that it is active as a transcrip- 
tion factor. Second, because detection limits of antibodies 
may differ and immunohistology is not quantitative, our as- 
says could have missed low amounts of MRFs or failed to de- 
tect additional variations in MRF levels which have func- 
tional significance. Third, due to the lack of a reliable double 
fluorescence system, it is not clear if all cells in a particular 
region express the same combination of MRFs, or if cells 
with different MRF expression patterns are intermingled. Fi- 
nally, an antibody may react with non-MRF proteins. The 
antibodies used here react with only a single MRF in precipi- 
tation and immunocytology assays, and each fails to react 
with those additional bHLH proteins (e.g., El2, Id) against 
which it has been tested (Wright et al.,  1991; Smith et al., 
1993).  Each antibody also reacts with only one MRF in 
mice, because each gave a distinct pattern of staining in the 
somites and each stained somites only when the correspond- 
ing MRF mRNA is expressed. Reaction of an antibody with 
additional proteins thus seems unlikely in E8.5-E10.5 em- 
bryos. 
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tiple myogenic cell lineages and signaling systems that occur 
in somites.  As determined by half somite transplantations, 
distinct  myogenic cell lineages  arise in the dorsal (medial) 
and ventral (lateral) regions of chicken somites (Ordahl and 
LeDouarin,  1992). We find that dorsal and ventral  somite 
cells,  and thus perhaps the two lineages  of myogenic cells, 
express distinct patterns of the MRFs. Also, a signal(s) from 
the neural  tube/notochord is required for differentiation  of 
the dorsal,  but not ventral,  myogenic  ceils (Christ et al., 
1992; Rong et al., 1992) and local signals allow survival of 
ventral dermamyotome in trunk, but not limb bud, somites 
(Tosney, K. W. 1994. J.  Cell Biochem.  18D[Suppl.]:462a). 
MRF expression  in the dorsal-medial  and  ventral-lateral 
regions of all somites and in the extended ventral regions of 
trunk somites may be activated by different combinations  of 
intercellular  and intracellular  mechanisms.  This possibility 
is supported by the finding that distinct regulatory elements 
govern  myogenin gene transcription  in dorsal and  ventral 
trunk somites  (Cheng  et al.,  1993; Yee and Rigby, 1993). 
Distinct regulatory elements also control myf-5 gene expres- 
sion  in  somite and  head  muscle  cells  (Papoutian  et  al., 
1993). 
Myogenic ceils may migrate to limb buds from the lateral 
surface of the ventral dermatome (Milaire,  1976) and appar- 
ently do not express MRFs during migration  (Buckingham, 
1992; Ordahl,  1993; Sassoon, 1993; Cheng et al., 1992; Yee 
and Rigby,  1993). Thus,  because cells in the ventral  myo- 
tome express a distinct MRF pattern and are located on the 
medial  side of the dermatome, they could be considered a 
third  type of myogenic cell, different from both the dorsal 
myotomal cells and the ventral  cells that  migrate  into the 
limb buds. The unexpectedly complex expression patterns of 
the MRF proteins thus provide molecular markers for subdo- 
mains of mouse somites and suggest that myogenic cells in 
the somites arise at multiple sites and via multiple molecular 
pathways and signals. 
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